COPD Trials in Montréal, Canada
Conditions / COPD / Montréal, Canada
COPD has been the subject of sustained clinical investigation across multiple research sites.
24 total trials for this combination
Showing top 10 of 24 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00463567 | 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2/PHASE3 |
| NCT02465567 | Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) | COMPLETED | PHASE3 |
| NCT05204888 | myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home | RECRUITING | NA |
| NCT01966107 | Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. | COMPLETED | PHASE4 |
| NCT02497001 | A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos) | COMPLETED | PHASE3 |
| NCT03443479 | Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure | COMPLETED | — |
| NCT01443845 | Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) | COMPLETED | PHASE4 |
| NCT00677807 | Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00920348 | The Canadian Cohort Obstructive Lung Disease | UNKNOWN | — |
| NCT03148210 | Undiagnosed COPD and Asthma Population Study (UCAP) | COMPLETED | NA |